Vemurafenib may overcome TNF-related apoptosis-inducing ligand (TRAIL) resistance in anaplastic thyroid cancer cells
- 3 August 2019
- journal article
- research article
- Published by Springer Nature in Endocrine
- Vol. 67 (1) , 117-123
Abstract
Purpose Anaplastic thyroid cancer (ATC) is rare but with poor prognosis. TRAIL can selectively induce apoptosis in cancer cells; however, resistance is quite common. Aim of our study was to evaluate TRAIL-induced apoptosis in ATC-derived cell lines, in vitro and in vivo, and the effect of combination with tyrosine kinase inhibitors (TKIs) selective for BRAF (vemurafenib) or Akt (MK-2206). Methods Four ATC-derived cell lines were used: C643, CAL62, HTh7, with activating mutation of RAS and copy gain of PI3K (HTh7) and, 8505C with activating mutation of BRAF. Cells were treated with TRAIL alone or in combination with vemurafenib or MK-2206. The pro-apoptotic effect of TRAIL alone or combined with TKIs was, also, evaluated in two mouse xenograft models (HTh7 and 8505C). Results C643, CAL62, and HTh7 cells were sensitive to TRAIL-induced apoptosis, whereas 8505C cells were resistant. Both in vitro and in vivo vemurafenib was able to increase the TRAIL-induced apoptosis in 8505C cells causing a slower tumor growth in 8505C xenograft compared to placebo, while MK-2206 did not have any additive effect on TRAIL treatment in HTh7 model. Conclusions TRAIL is a promising therapeutic agent in ATC and in case of resistance vemurafenib may be a valid complementary therapy.Keywords
This publication has 27 references indexed in Scilit:
- Akt-phosphorylated Mitogen-activated Kinase-activating Death Domain Protein (MADD) Inhibits TRAIL-induced Apoptosis by Blocking Fas-associated Death Domain (FADD) Association with Death Receptor 4Journal of Biological Chemistry, 2010
- Knockdown ofIG20Gene Expression Renders Thyroid Cancer Cells Susceptible to ApoptosisThe Journal of Clinical Endocrinology & Metabolism, 2009
- Anaplastic thyroid cancer: molecular pathogenesis and emerging therapiesEndocrine-Related Cancer, 2009
- Resistance to TRAIL-induced apoptosis caused by constitutional phosphorylation of Akt and PTEN in acute lymphoblastic leukemia cellsExperimental Hematology, 2008
- Mutation of the PIK3CA Gene in Anaplastic Thyroid CancerCancer Research, 2005
- IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISCOncogene, 2004
- Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancerJournal of Medical Genetics, 2004
- Regulation of Apo2L/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Thyroid Carcinoma CellsThe American Journal of Pathology, 2002
- Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptorsNature, 1997
- Identification and characterization of a new member of the TNF family that induces apoptosisImmunity, 1995